Sergey Tereschenko

Statistics

Publications

Citations

3.9K

H-Index

Active since

2009

Affiliations

National Medical Research Center of Cardiology(Current)

University of Toronto

Semmelweis University

St. Michael's Hospital

Mossakowski Medical Research Institute, Polish Academy of Sciences

Sergey Tereschenko is an author at National Medical Research Center of Cardiology specializing in medicine, diabetes mellitus, and cardiovascular pharmacotherapy.

Publications per year

2009–2024

Publications

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction

Scott D. Solomon, Muthiah Vaduganathan, Brian Claggett et al. · JACC Heart Failure · 2022 · 165 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy

Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson et al. · Diabetes Care · 2020 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Non-immunogenic recombinant staphylokinase versus alteplase for patients with massive pulmonary embolism: a randomized open-label, multicenter, parallel-group, non-inferiority trial, FORPE

S Leontyev, Sergey Tereschenko, I. S. Yavelov et al. · Journal of Thrombosis and Haemostasis · 2024 · 15 citations

Medicine, Clinical Sciences, Surgery +14

1–5 of 6